Published in Pharmacol Biochem Behav on July 10, 2006
Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J Neurosci (2009) 1.24
Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci (2008) 1.22
Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Horm Behav (2009) 1.05
Progesterone in Peri- and Postmenopause: A Review. Geburtshilfe Frauenheilkd (2014) 0.81
Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones. J Physiol (2014) 0.80
Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABA A-related mechanistic probes. Psychopharmacology (Berl) (2008) 0.80
DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. Psychopharmacology (Berl) (2015) 0.76
A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A (1998) 3.33
Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci U S A (1998) 2.18
Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A (1998) 2.12
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Eur J Cancer Prev (2004) 1.41
[Core symptoms of depression. Effectiveness of antidepressant therapy]. Nervenarzt (2009) 1.40
Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry (1998) 1.38
Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology (1999) 1.23
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry (2008) 1.20
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci Lett (2001) 1.20
St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry (1998) 1.17
Clinical outcome of autogenous bone blocks or guided bone regeneration with e-PTFE membranes for the reconstruction of narrow edentulous ridges. Clin Oral Implants Res (1999) 1.16
Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis (2006) 1.15
Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol (1996) 1.11
Implant-retained mandibular overdentures with Brånemark System MKII implants: a prospective comparative study between delayed and immediate loading. Int J Oral Maxillofac Implants (2001) 1.08
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol (1999) 1.07
Dizziness in an older community dwelling population: a multifactorial syndrome. J Nutr Health Aging (2009) 1.07
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport (2000) 1.06
Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry (2006) 1.04
Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron (1994) 1.04
The SIMA-project: effects of 1 year cognitive and psychomotor training on cognitive abilities of the elderly. Behav Brain Res (1996) 1.03
Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J Neurol (1999) 1.03
Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry (1999) 1.01
Identification and characterization of a 3',5'-cyclic adenosine monophosphate-responsive element in the human corticotropin-releasing hormone gene promoter. Mol Endocrinol (1992) 1.01
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Brain Res Rev (2001) 1.01
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience (2011) 1.00
Progesterone-induced changes in sleep in male subjects. Am J Physiol (1997) 1.00
Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther (1997) 0.98
The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol (1994) 0.96
Stimulation of brain pregnenolone synthesis by mitochondrial diazepam binding inhibitor receptor ligands in vivo. J Neurochem (1993) 0.95
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry (2003) 0.95
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol (2012) 0.94
The frailty syndrome in general practitioner care: a pilot study. Z Gerontol Geriatr (2010) 0.93
Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig. Mol Pharmacol (1998) 0.93
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry (2004) 0.93
Chemistry, binding affinities, and behavioral properties of a new class of "antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. J Med Chem (1993) 0.92
Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS. Neurology (1999) 0.91
Mirtazapine: an inhibitor of cortisol secretion that does not influence growth hormone and prolactin secretion. J Clin Psychopharmacol (2000) 0.91
Vertical distraction osteogenesis of edentulous ridges for improvement of oral implant positioning: a clinical report of preliminary results. Int J Oral Maxillofac Implants (2001) 0.91
Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol (2012) 0.91
Neuroactive steroids as modulators of depression and anxiety. Neuroscience (2005) 0.91
Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry (2000) 0.91
Pharmacology of neurosteroid biosynthesis. Role of the mitochondrial DBI receptor (MDR) complex. Ann N Y Acad Sci (1994) 0.90
Behavior of implants in bone grafts or free flaps after tumor resection. Clin Oral Implants Res (2000) 0.90
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology (2001) 0.89
Alpha-thujone reduces 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology (2004) 0.89
Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol (1998) 0.88
Shift work increases the frequency of duodenal ulcer in H pylori infected workers. Occup Environ Med (2006) 0.88
Predictors for occasional and recurrent falls in community-dwelling older people. Z Gerontol Geriatr (2009) 0.87
Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J Clin Invest (1996) 0.87
Immediate transmucosal implant placement in molar extraction sites: a 12-month prospective multicenter cohort study. Clin Oral Implants Res (2008) 0.85
Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. J Psychiatr Res (2000) 0.85
Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. Mol Psychiatry (2006) 0.85
Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study. Dig Liver Dis (2008) 0.85
Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases. Curr Neuropharmacol (2013) 0.85
The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology (2001) 0.84
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives. J Pharmacol Exp Ther (1993) 0.84
Simultaneous detection of glutamic acid decarboxylase and reelin mRNA in adult rat neurons using in situ hybridization and immunofluorescence. Brain Res Brain Res Protoc (1998) 0.83
Flunitrazepam has an inverse agonistic effect on recombinant alpha6beta2gamma2-GABAA receptors via a flunitrazepam-binding site. J Biol Chem (1997) 0.83
Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients. Neuropsychobiology (2008) 0.83
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology (2003) 0.82
Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders. Mol Psychiatry (2001) 0.82
Haloperidol-induced cell death--mechanism and protection with vitamin E in vitro. Neuroreport (1995) 0.82
Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. J Clin Endocrinol Metab (1990) 0.82
Tiagabine improves panic and agoraphobia in panic disorder patients. J Clin Psychiatry (2001) 0.82
Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects. Psychoneuroendocrinology (1999) 0.82